Pharma's lobbying dollars, Alnylam's future, and diversity in Covid-19 studies

The Readout Loud - A podcast by STAT - Thursdays

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

Is pharma scared of Kamala Harris? Are there second acts in biotech? And why don't Covid-19 trials look more diverse?